| 2021-08-17 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 14,779 0.0303% | $47.56 | $702,889 | -47.52% | |
| 2019-08-06 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 6,790 0.023% | $8.85 | $60,088 | +5.68% | |
| 2019-03-01 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 1,620 0.0064% | $8.03 | $13,009 | +28.72% | |
| 2019-02-06 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 7,642 0.0313% | $7.74 | $59,123 | +38.82% | |
| 2018-03-12 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 7,000 0.0202% | $12.75 | $89,235 | -61.46% | |
| 2018-03-02 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 1,750 0.0079% | $20.00 | $35,000 | -61.31% | |
| 2018-01-16 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 875 0.0043% | $20.00 | $17,500 | -56.04% | |
| 2017-12-18 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 875 0.005% | $20.00 | $17,500 | -55.76% | |
| 2017-11-30 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 875 0.0051% | $20.00 | $17,500 | -54.28% | |
| 2017-11-13 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 3,500 0.0198% | $16.97 | $59,381 | -46.58% | |
| 2017-08-28 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 3,500 0.0208% | $15.00 | $52,500 | +5.43% | |
| 2017-07-10 | Sale | Protagonist Therapeutics, Inc. PTGX | Chief Scientific Officer | 3,500 0.0212% | $12.68 | $44,380 | +27.14% |